₹584.30 16.25 (2.86%)
03:51 PM, 20-Jan-2025₹584.25 16.45 (2.90%)
03:31 PM, 20-Jan-2025BSE : 540222
NSE : LAURUSLABS
Sector : Health care
ISIN Code : INE947Q01028
Last Updated: 20-Jan-2025 | 10:21 AM IST
Market Cap (₹ Cr) | 31,503 |
Traded Value (₹ Cr) | 4.25 |
Volume (Shares) | 72,691 |
Face Value (₹) | 2 |
52-Week High (₹) | 619.50 |
52-Week High Date | 07-Jan-2025 |
52-Week Low (₹) | 358.70 |
52-Week Low Date | 25-Jan-2024 |
All Time High (₹) | 723.55 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 59.60 |
All Time Low Date | 07-Aug-2019 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 31,500 |
EPS - TTM (₹) [C] | 2.43 |
P/E Ratio (X) [C] | 240.43 |
Face Value (₹) | 2 |
Latest Dividend (%) | 20.00 |
Latest Dividend Date | 06-Nov-2024 |
Dividend Yield (%) | 0.14 |
Book Value Share (₹) [C] | 76.67 |
P/B Ratio (₹) [C] | 7.62 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
SBI Large & Midcap Fund (IDCW) | 337.51 | 56,00,000 | 1.15 |
SBI Large & Midcap Fund (G) | 337.51 | 56,00,000 | 1.15 |
SBI Large & Midcap Fund - Direct (G) | 337.51 | 56,00,000 | 1.15 |
SBI Large & Midcap Fund - Direct (IDCW) | 337.51 | 56,00,000 | 1.15 |
SBI Magnum Midcap Fund (G) | 147.67 | 24,50,194 | 0.68 |
SBI Magnum Midcap Fund (IDCW) | 147.67 | 24,50,194 | 0.68 |
SBI Magnum Midcap Fund - Direct (G) | 147.67 | 24,50,194 | 0.68 |
SBI Magnum Midcap Fund - Direct (IDCW) | 147.67 | 24,50,194 | 0.68 |
Franklin India Prima Fund - (G) | 146.00 | 24,22,358 | 1.16 |
Franklin India Prima Fund - (IDCW) | 146.00 | 24,22,358 | 1.16 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 564.10 590.00 |
Week Low/High (₹) | 541.70 590.00 |
Month Low/High (₹) | 541.70 619.00 |
Year Low/High (₹) | 360.85 619.00 |
All time Low/High (₹) | 59.60 724.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 4.55% | 4.51% | 0.97 | 1.12% |
1 Month | 4.48% | 4.48% | -1.24 | -1.03% |
3 Month | 22.97% | 22.96% | -5.11 | -6.07% |
6 Month | 32.74% | 32.66% | -4.38 | -4.84% |
1 Year | 45.37% | 45.39% | 7.91 | 8.22% |
3 Year | 20.35% | 20.40% | 29.61 | 31.47% |
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru
Registered Office: Plot No 21 Jawaharlal Nehru, Pharma City Parawada,Visakhapatnam,Andhra Pradesh-531021 Ph: 91-891-3061222
1. What's the Laurus Labs Ltd share price today?
Laurus Labs Ltd share price was Rs 584.30 at 03:51 PM IST on 20th Jan 2025. Laurus Labs Ltd share price was up by 2.86% over the previous closing price of Rs 568.05. Laurus Labs Ltd share price trend:
2. How can I quickly analyse the performance of the Laurus Labs Ltd stock?
The performance of the Laurus Labs Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Laurus Labs Ltd?
Laurus Labs Ltd has a market capitalisation of Rs 31,503 crore.
4. What is Laurus Labs Ltd's 52-week high/low share price?
The Laurus Labs Ltd’s 52-week high share price is Rs 619.50 and 52-week low share price is Rs 358.70.
5. Is the Laurus Labs Ltd profitable?
On a consolidated basis, Laurus Labs Ltd reported a profit of Rs 42.44 crore on a total income of Rs 1,196.74 crore for the quarter ended 2024. For the year ended Sep 2024, Laurus Labs Ltd had posted a profit of Rs 17.72 crore on a total income of Rs 1,228.30 crore.
6. Which are Laurus Labs Ltd’s peers in the Health care sector?
Laurus Labs Ltd’s top 5 peers in the Health care sector are Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma, Laurus Labs, J B Chemicals &, Gland Pharma, Suven Pharma.
7. Who owns how much in Laurus Labs Ltd?
Key changes to the Laurus Labs Ltd shareholding are as follows: